CDK8/19-IN-4

CDK8/19-IN-4 is an orally active CDK8/19 inhibitor. CDK8/19-IN-4 directly binds to and inhibits CDK8/Cyclin C, and inhibits CDK19/Cyclin C. The IC50 values of CDK8/19-IN-4 for CDK8, CDK19, CDK7, and CDK6 are 24.5 nM, 38.6 nM, 412.5 nM, and 694.4 nM, respectively, and the Kd for CDK8 is 46.44 nM. CDK8/19-IN-4 promotes Treg differentiation through the STAT1 and TGF-β/Smad signaling pathways, reduces STAT1 phosphorylation and enhances Smad2/3 activation, and inhibits IL-17A/TNF-α-induced keratinocyte proliferation and inflammatory mediator production. CDK8/19-IN-4 alleviates skin inflammation in the IMQ-induced psoriasis-like model. CDK8/19-IN-4 can be used for research on psoriasis.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Formel: C23H22N4O3S
  • Molecular Weight:434.51
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Protokoll
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Alle STAT Isoform-spezifische Produkte anzeigen

More

Alle TGF-beta/Smad Isoform-spezifische Produkte anzeigen

More

Alle Interleukin Related Isoform-spezifische Produkte anzeigen

More
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00